Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Healthcare ‘freakonomics’

Understanding the economics of the healthcare market enables us to limit the impact of the system’s inherent failures

Rare disease patients face 5-7 year wait for diagnosis

Doctors often lack time and resources to manage patients

- PMLiVE

Switzerland and pharma forge pricing and access pact

Prices of 2,500 drugs set to fall when price referencing scheme begins

- PMLiVE

Boehringer backs gene therapy firm Eyevensys

Invests in French eye disease specialist

- PMLiVE

Sanofi supports Clexane with Spanish VTE apps

The free iPhone, iPad and Android apps are for healthcare professionals

- PMLiVE

EMA recommends heart risk restriction for Servier’s Protelos

Use of osteoporosis drug likely to be further tightened up

Bupa appoints chief risk officer

Gerry Kelly joins from Lloyds

The evolving landscape of medical education

With new stakeholders, multimedia channels and budget constraints, medical education is changing fast

- PMLiVE

BMS plans major expansion of Orencia plant

Will invest $250m in biologics manufacturing facility

- PMLiVE

Lilly “plans to axe a third of US sales reps”

Cuts come ahead of key patent expiries for Cymbalta and Evista

- PMLiVE

Sanofi’s four-strain flu vaccine Vaxigrip under review in EU

Pharma company also launches production of ingredient for malaria drug

Zosano appoints Chris Krueger as chief business officer

He joins from Ardea Biosciences

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links